Trientine, a Copper-Chelating Agent, Induced Apoptosis in Murine Fibrosarcoma Cells In Vivo and In Vitro-Reference-Cited by-同舟云学术

Trientine, a Copper-Chelating Agent, Induced Apoptosis in Murine Fibrosarcoma Cells In Vivo and In Vitro

Published:2007 Issue:2 Volume:69 Page:137-142
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

HAYASHI Masanobu¹,NISHIYA Hide¹,CHIBA Toshiaki¹,ENDOH Daiji¹,KON Yasuhiro²,OKUI Toyo³

Affiliation:

1. Department of Veterinary Radiology, School of Veterinary Medicine, Rakuno Gakuen University

2. Laboratory of Anatomy, Graduate School of Veterinary Medicine, Hokkaido University

3. Hokkaido Institute of Public Health

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

http://www.jstage.jst.go.jp/article/jvms/69/2/69_2_137/_pdf

Reference36 articles.

1. Specific binding of angiogenin to calf pulmonary artery endothelial cells.

2. Mechanisms and therapeutic implications of angiogenesis

3. 3. Brem, S., Grossman, S.A., Carson, K.A., New, P., Phuphanich, S., Alavi, J.B. and Mikkelsen, T. 2005. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro-oncology 7: 246-253.

4. 4. Brem, S., Zagzag, D., Tsanaclis, A.M.C., Gatley, S., Elkouby, M.P. and Brien, S.E. 1990. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am. J. Pathol. 137: 1121-1142.

5. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance;Drug Resistance Updates;2024-01

2. Copper in Gynecological Diseases;International Journal of Molecular Sciences;2023-12-17

3. Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials;Cancer Letters;2023-09

4. The copper age in cancer treatment: From copper metabolism to cuproptosis;Progress in Materials Science;2023-09

5. The combination of disulfiram and copper for cancer treatment;Drug Discovery Today;2020-06